Stoke Therapeutics
STOK
#4801
Rank
A$2.81 B
Marketcap
A$47.59
Share price
-2.58%
Change (1 day)
207.50%
Change (1 year)

Earnings for Stoke Therapeutics (STOK)

Earnings in 2025 (TTM): A$0.75 Million

According to Stoke Therapeutics's latest financial reports the company's current earnings are A$0.18 Billion. , an increase over its 2024 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Stoke Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -A$9.63 Million-92.26%
2024 -A$0.13 Billion-15.01%
2023 -A$0.15 Billion3.59%
2022 -A$0.15 Billion17.79%
2021 -A$0.12 Billion64.24%
2020 -A$73.06 Million61.62%
2019 -A$45.21 Million158.17%
2018 -A$17.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.21 Billion 2,049.93%๐Ÿ‡บ๐Ÿ‡ธ USA